» Authors » Sabrina Senatore

Sabrina Senatore

Explore the profile of Sabrina Senatore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 205
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rovida F, Faccini M, Molina Grane C, Cassaniti I, Senatore S, Rossetti E, et al.
Travel Med Infect Dis . 2025 Jan; 64:102795. PMID: 39755224
Introduction: Here we reported the virological, entomological and epidemiological characteristics of the large autochthonous outbreak of dengue (DENV) occurred in a small village of the Lombardy region (Northern Italy) during...
2.
Fappani C, Gori M, Bianchi S, Senatore S, Colzani D, Faccini M, et al.
J Med Virol . 2024 Aug; 96(9):e29892. PMID: 39210621
In line with European trends, since 2023 Lombardy (Northern Italy) is experiencing a resurgence of measles and an increased number of reported cases of fever and rash. Measles discarded cases...
3.
Gori M, Fappani C, Bianchi S, Senatore S, Colzani D, Pasutto P, et al.
Euro Surveill . 2024 Apr; 29(16). PMID: 38639092
Since late 2023, the Metropolitan City of Milan and surrounding areas (northern Italy) have been experiencing a resurgence of measles, with most cases detected starting from January 2024. During this...
4.
Consolazio D, Murtas R, Tunesi S, Lamberti A, Senatore S, Faccini M, et al.
Front Epidemiol . 2024 Mar; 2:891162. PMID: 38455311
Background: In the context of the fourth wave of the COVID-19 pandemic in Italy, which occurred in correspondence with the outbreak of the Omicron variant, it became fundamental to assess...
5.
Cassaniti I, Ferrari G, Senatore S, Rossetti E, Defilippo F, Maffeo M, et al.
Euro Surveill . 2023 Sep; 28(37). PMID: 37707980
In August 2023, six locally acquired dengue virus 1 infections were detected in Lodi province, Lombardy Region, in northern Italy, where the vector is present. Four cases were hospitalised, none...
6.
Russo A, Faccini M, Riusso A, Lamberti A, Tunesi S, Senatore S, et al.
Epidemiol Prev . 2023 May; 47(3):137-151. PMID: 37154301
Background: currently, individuals at risk of adverse outcomes for COVID-19 can access to vaccination and pharmacological interventions. But, during the first epidemic wave, there were no treatments or therapeutic strategies...
7.
Bianchi S, Gori M, Fappani C, Ciceri G, Canuti M, Colzani D, et al.
Viruses . 2022 May; 14(5). PMID: 35632809
Despite the existence of an effective live-attenuated vaccine, measles can appear in vaccinated individuals. We investigated breakthrough measles cases identified during our surveillance activities within the measles/rubella surveillance network (MoRoNet)...
8.
Ricci M, Fillo S, Ciammaruconi A, Lista F, Ginevra C, Jarraud S, et al.
Life Sci Alliance . 2022 Mar; 5(6). PMID: 35236759
serogroup 1 (Lp1) sequence type (ST) 23 is one of the most commonly detected STs in Italy where it currently causes all investigated outbreaks. ST23 has caused both epidemic and...
9.
Dallagiacoma G, Allora A, Salvati S, Cocciolo G, Capraro M, Lamberti A, et al.
Vaccines (Basel) . 2021 Jul; 9(7). PMID: 34210044
Diabetic patients are at higher risk of developing infectious diseases and severe complications, compared to the general population. Almost no data is available in the literature on influenza immunization in...
10.
Villa S, Tagliani E, Borroni E, Castellotti P, Ferrarese M, Ghodousi A, et al.
Eur Respir J . 2021 May; 58(3). PMID: 34049944
No abstract available.